Does India Need to Upgrade Its Biosecurity Measures?
Table of Contents
Source: The Hindu
Relevance:
(GS Paper III – Science & Technology, Internal Security)
Important Key Concepts for Prelims and Mains:
For Prelims:
- Biosecurity, Biosafety, Biological Weapons Convention (BWC), Ricin, Recombinant DNA Guidelines 2017, Environment Protection Act 1986, WMD Act 2005, Global Health Security Index, Australia Group
For Mains:
- Bio-risk governance, non-state actors, emerging biothreats, lab oversight, synthetic biology, national security, public health surveillance, biodefence strategy
Why in News?
The rapid evolution of new-age biotechnologies has dramatically expanded human ability to manipulate biological systems. As these tools become more accessible, the potential for deliberate misuse—by states or non-state actors—has increased. This has renewed attention on whether India’s existing biosecurity architecture is strong enough to manage escalating risks.
What is Biosecurity?
Biosecurity refers to systems, practices, and policies aimed at preventing the intentional misuse of biological agents, toxins, or technologies.
It includes:
- Safeguarding laboratories handling dangerous pathogens
- Detecting and containing deliberate disease outbreaks
- Preventing harmful manipulation of biological materials
- Protecting human, livestock, and plant health
How it differs from biosafety:
- Biosafety → prevents accidental release of pathogens
- Biosecurity → prevents intentional misuse
A strong biosafety foundation supports overall biosecurity.
The Biological Weapons Convention (BWC)
- Established in 1975
- First global treaty to ban the development, production, and stockpiling of biological weapons
- Requires signatories to destroy existing stockpiles
- Has contributed to a long period with minimal state-level bioweapon use
However, new technologies and non-state actors are creating fresh risks that the BWC framework must keep up with.
Why India Needs Stronger Biosecurity
Several factors heighten India’s vulnerability:
1. Geographic and ecological risk
India’s size, biodiversity, dense population, and porous borders increase exposure to cross-border biological threats.
2. Agricultural dependence
Biological attacks on crops or livestock could disrupt food security and economic stability.
3. Growing interest of non-state actors
There have been reports of attempts to prepare Ricin, a toxin derived from castor oil, for use in terror attacks — signalling that extremist groups may explore biological tools.
4. Rapid spread of biotechnology
Affordable genetic editing, open-access biological databases, and DIY labs increase the risk of amateur or malicious experimentation.
India’s Existing Biosecurity Governance
Multiple agencies oversee different aspects:
Human Health & Research
- Department of Biotechnology (DBT): Lab governance, research safety
- National Centre for Disease Control (NCDC): Surveillance & outbreak response
Animal Health
- Department of Animal Husbandry & Dairying: Livestock diseases, transboundary bio-risks
Plant Health
- Plant Quarantine Organisation of India: Agricultural import/export regulation
Legal and Policy Framework
- Environment (Protection) Act, 1986: Regulates hazardous microorganisms, GMOs
- Biosafety Rules, 1989: Oversight of genetically engineered organisms
- Recombinant DNA Research Guidelines, 2017: Biocontainment norms
- WMD Act, 2005: Criminalises biological weapons
Disaster Preparedness
- NDMA’s Guidelines for managing biological disasters
International Cooperation
- Member of BWC and the Australia Group
The Gap
Despite many bodies, India lacks:
- A unified national biosecurity framework
- Updated laws addressing modern genetic tools
- Sufficient capacity for rapid response
India currently ranks 66th on the Global Health Security Index—a warning sign that response capabilities lag behind detection systems.
How Other Countries Are Responding
United States
- National Biodefense Strategy (2022–28) integrates health + defence
- 2024 Synthetic DNA Screening Guidance requires companies to verify DNA orders to prevent pathogen misuse
European Union
- EU Health Security Framework (2022)
- Strong dual-use research controls under Horizon Europe
- One Health–based integrated biosecurity
China
- Biosecurity Law (2021) treats biotechnology and genetic data as national security assets
- Centralised control over research and genetic material
Australia
- Biosecurity Act (2015) unifies human, animal, plant biosecurity
- Now expanded to synthetic biology
United Kingdom
- Biological Security Strategy (2023) emphasises biosurveillance + rapid response
Risks Ahead for India
Without upgrades, India faces:
- Vulnerability to deliberate biological attacks
- Inability to contain engineered pathogens
- Threats to billions of lives, food systems, and national security
- Regulatory gaps in synthetic biology, gene editing, and DNA synthesis markets
A national biosecurity framework must:
- Coordinate all agencies
- Identify infrastructure gaps
- Integrate new tools like microbial forensics and social-media-based outbreak detection
Conclusion
India’s expanding biotech ecosystem demands a modern, unified, and forward-looking biosecurity system. While multiple agencies and laws exist, they were designed for an earlier era. To safeguard national security and public health, India must upgrade its legal frameworks, strengthen inter-agency coordination, and invest in advanced biodefence technologies. As biothreats evolve rapidly, India’s biosecurity preparedness must evolve even faster.
UPSC PYQ
Q. The Cartagena Protocol, to which India is a party, is related to: (CAPF 2020)
(a) Combat the greenhouse gases and reduce global warming and climate change
(b) Biosafety, negotiated under the aegis of the Convention on Biological Diversity
(c) Combat the ozone-depleting substances to protect human lives from diseases
(d) Combat the phenomenon of desertification by improving dry land farming in dry regions
Correct Answer: (b)
Explanation
- The Cartagena Protocol on Biosafety (2000) is a supplementary agreement to the Convention on Biological Diversity (CBD).
- It regulates the safe handling, transport, and use of Living Modified Organisms (LMOs) created through modern biotechnology.
- Its primary purpose is to prevent potential adverse effects on biodiversity, with due consideration to human health.
CARE MCQ
Q. Consider the following statements regarding the Cartagena Protocol on Biosafety:
- The Cartagena Protocol is a legally binding agreement under the Convention on Biological Diversity aimed at ensuring the safe handling and transfer of living modified organisms.
- The Protocol was adopted in Cartagena, Colombia, where negotiations concluded in 1999.
Which of the statements given above is/are correct?
(a) 1 only
(b) 2 only
(c) Both 1 and 2
(d) Neither 1 nor 2
Correct Answer: (a) 1 only
Explanation:
- Statement 1 is correct:
- The Cartagena Protocol on Biosafety is legally binding and falls under the Convention on Biological Diversity (CBD).
- It aims to ensure the safe transfer, handling, and use of living modified organisms (LMOs) resulting from modern biotechnology, considering risks to biodiversity and human health.
- Statement 2 is not correct:
- Although the Protocol was named after Cartagena, Colombia, the city where negotiations were initially planned, the final adoption took place in Montreal, Canada on January 29, 2000, not in Cartagena.
